Intelligent Net Debt from 2010 to 2024

INBS Stock

USD 1.61 0.10 6.62%

Intelligent Bio Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Intelligent Bio Solutions minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-06-30

Previous Quarter

-5.4 M

Current Value

-3.2 M

Quarterly Volatility

7.6 M

Covid

Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 158.8 K or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.89, Dividend Yield of 0.0 or PTB Ratio of 0.37. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.

Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Net Debt Growth Pattern

Below is the plot of the Net Debt of Intelligent Bio Solutions over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Intelligent Bio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Intelligent Net Debt Regression Statistics

	Arithmetic Mean	453,476
	Coefficient Of Variation	1,222
	Mean Deviation	4,516,614
	Median	3,478,289
	Standard Deviation	5,540,767
	Sample Variance	30.7T
	Range	17.5M
	R-Value	(0.64)
	Mean Square Error	19.3T
	R-Squared	0.41
	Significance	0.01
	Slope	(798,039)
	Total Sum of Squares	429.8T

Intelligent Net Debt History

	2024	-5.2 M
	2023	-5.4 M
	2022	-201.6 K
	2021	-8.2 M
	2020	-12.6 M
	2019	4.7 M
	2018	4.9 M

Intelligent Bio Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Deferred Long Term Liab	Property Plant Equipment	Long Term Debt	Short Term Investments	Intangible Assets
Total Assets		0.97	-0.95	-0.78	0.8	-0.26	0.96	-0.86	-0.13	0.93	0.95	0.95	-0.92	-0.91	0.93	0.55	-0.32	0.5	-0.32	-0.32	-0.35
Total Stockholder Equity	0.97		-0.96	-0.85	0.77	-0.41	0.93	-0.89	-0.18	0.9	0.92	0.99	-0.96	-0.95	0.91	0.67	-0.52	0.55	-0.52	-0.52	-0.54
Net Debt	-0.95	-0.96		0.7	-0.69	0.34	-0.96	0.9	0.26	-0.97	-0.91	-0.95	0.9	0.89	-0.97	-0.64	0.39	-0.35	0.39	0.39	0.41
Retained Earnings	-0.78	-0.85	0.7		-0.65	0.48	-0.66	0.74	-0.01	-0.59	-0.76	-0.86	0.91	0.89	-0.57	-0.78	0.68	-0.82	0.68	0.68	0.71
Accounts Payable	0.8	0.77	-0.69	-0.65		0.01	0.73	-0.67	0.13	0.74	0.78	0.76	-0.76	-0.74	0.7	0.33	-0.17	0.4	-0.17	-0.17	-0.16
Total Liab	-0.26	-0.41	0.34	0.48	0.01		-0.25	0.35	0.47	-0.21	-0.1	-0.43	0.42	0.48	-0.24	-0.65	0.67	-0.4	0.67	0.67	0.68
Total Current Assets	0.96	0.93	-0.96	-0.66	0.73	-0.25		-0.77	-0.08	0.97	0.93	0.89	-0.83	-0.82	0.98	0.53	-0.27	0.27	-0.27	-0.27	-0.29
Short Term Debt	-0.86	-0.89	0.9	0.74	-0.67	0.35	-0.77		0.49	-0.82	-0.81	-0.94	0.93	0.94	-0.81	-0.67	0.43	-0.57	0.43	0.43	0.44
Common Stock	-0.13	-0.18	0.26	-0.01	0.13	0.47	-0.08	0.49		-0.17	0.04	-0.27	0.23	0.31	-0.21	-0.18	0.14	-0.18	0.14	0.14	0.14
Net Receivables	0.93	0.9	-0.97	-0.59	0.74	-0.21	0.97	-0.82	-0.17		0.92	0.88	-0.83	-0.82	0.97	0.56	-0.2	0.18	-0.2	-0.2	-0.2
Net Tangible Assets	0.95	0.92	-0.91	-0.76	0.78	-0.1	0.93	-0.81	0.04	0.92		0.9	-0.89	-0.85	0.88	0.6	-0.3	0.39	-0.3	-0.3	-0.3
Net Invested Capital	0.95	0.99	-0.95	-0.86	0.76	-0.43	0.89	-0.94	-0.27	0.88	0.9		-0.98	-0.98	0.88	0.7	-0.52	0.6	-0.52	-0.52	-0.54
Short Long Term Debt	-0.92	-0.96	0.9	0.91	-0.76	0.42	-0.83	0.93	0.23	-0.83	-0.89	-0.98		1.0	-0.8	-0.77	0.51	-0.67	0.51	0.51	0.52
Capital Stock	-0.91	-0.95	0.89	0.89	-0.74	0.48	-0.82	0.94	0.31	-0.82	-0.85	-0.98	1.0		-0.8	-0.77	0.52	-0.68	0.52	0.52	0.54
Net Working Capital	0.93	0.91	-0.97	-0.57	0.7	-0.24	0.98	-0.81	-0.21	0.97	0.88	0.88	-0.8	-0.8		0.47	-0.26	0.2	-0.26	-0.26	-0.27
Current Deferred Revenue	0.55	0.67	-0.64	-0.78	0.33	-0.65	0.53	-0.67	-0.18	0.56	0.6	0.7	-0.77	-0.77	0.47		-0.61	0.5	-0.61	-0.61	-0.61
Deferred Long Term Liab	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61		-0.58	1.0	1.0	0.99
Property Plant Equipment	0.5	0.55	-0.35	-0.82	0.4	-0.4	0.27	-0.57	-0.18	0.18	0.39	0.6	-0.67	-0.68	0.2	0.5	-0.58		-0.58	-0.58	-0.63
Long Term Debt	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58		1.0	0.99
Short Term Investments	-0.32	-0.52	0.39	0.68	-0.17	0.67	-0.27	0.43	0.14	-0.2	-0.3	-0.52	0.51	0.52	-0.26	-0.61	1.0	-0.58	1.0		0.99
Intangible Assets	-0.35	-0.54	0.41	0.71	-0.16	0.68	-0.29	0.44	0.14	-0.2	-0.3	-0.54	0.52	0.54	-0.27	-0.61	0.99	-0.63	0.99	0.99

Click cells to compare fundamentals

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-5.4 M	-5.2 M
Net Debt To EBITDA	0.62	0.65

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intelligent Net Debt from 2010 to 2024

Latest Intelligent Bio's Net Debt Growth Pattern

Intelligent Net Debt Regression Statistics

Intelligent Net Debt History

Other Fundumenentals of Intelligent Bio Solutions

Intelligent Bio Net Debt component correlations

About Intelligent Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Intelligent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY